Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Rescinnamine
Drug ID BADD_D01925
Description Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from _Rauwolfia serpentina_ and other species of _Rauwolfia_.
Indications and Usage For the treatment of hypertension.
Marketing Status approved
ATC Code C02AA01
DrugBank ID DB01180
KEGG ID D00198
MeSH ID C084826
PubChem ID 5280954
TTD Drug ID D0G8NJ
NDC Product Code Not Available
UNII Q6W1F7DJ2D
Synonyms rescinnamine | Moderil
Chemical Information
Molecular Formula C35H42N2O9
CAS Registry Number 24815-24-5
SMILES COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)O C)OC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abscess11.01.08.001--Not Available
Angina pectoris24.04.04.002; 02.02.02.002--
Back pain15.03.04.005--
Bronchitis22.07.01.001; 11.01.09.001--
Bursitis12.04.03.010; 15.04.01.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Cough22.02.03.001--
Dermatitis23.03.04.002--Not Available
Dermatitis bullous23.03.01.002--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Discomfort08.01.08.003--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Dysgeusia17.02.07.003; 07.14.03.001--
Endocrine disorder05.09.01.001--Not Available
Erythema23.03.06.001--Not Available
Eye irritation06.04.05.003--Not Available
Eyelid oedema06.04.04.004; 23.04.01.003; 10.01.05.001--Not Available
Gastritis07.08.02.001--
Gastrointestinal pain07.01.05.005--
Gingivitis07.09.10.002; 11.01.04.013--
Headache17.14.01.001--
Herpes zoster23.11.05.005; 17.09.03.026; 11.05.02.003--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hypertrichosis23.02.04.002--
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hypothyroidism14.11.01.012; 05.02.03.001--
The 1th Page    1 2 3    Next   Last    Total 3 Pages